Possible transforming activity of interferon regulatory factor 2 in tumorigenicity assay of NIH3T3 cells transfected with DNA from chronic myelogenous leukemia patients

Leukemia Research

Volumn 20, Issue 7, 1996, Pages 601-605

  Futaki, Makoto ^a   Inokuchi, Koiti ^a   Hanawa, Hideki ^a   Tanosaki, Sakae ^a   Dan, Kazuo ^a   Nomura, Takeo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chronic myelogenous leukemia; Interferon regulatory factor genes; Transforming genes; Tumorigenicity assay

Indexed keywords

DNA; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL; CARCINOGENICITY; CELL STRAIN 3T3; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; DNA TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

EID: 0030198619     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00013-6     Document Type: Article

References (9)

1. 1. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T. & Taniguchi T. (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729.
2. 2. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M. & Taniguchi T. (1993) Anti-oncogenic and oncogenic potentials of interferon regulatory factor-1 and -2. Science 259, 971.
3. 3. Krontiris T. G. & Cooper G. M. (1981) Transforming activity of human tumor DNAs. Proc. natn. Acad. Sci. USA 78, 1181.
4. 4. Futaki M., Inokuchi K., Dan K. & Nomura T. (1991) Activation of bcr-abl fusion gene and ras oncogenes in chronic myelogenous leukemia. Leuk. Lymph. 5, 163.
5. 5. Futaki M., Inokuchi K., Matsuoka H., Miyake K., Dan K. & Nomura T. (1992) Relationship of the type of bcr-abl hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia. Leukemia Res. 16, 1071.
6. 6. Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Bohlke J. U., Bos J. L., Seliger H. & Bartram C. R. (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders and myelodysplastic syndromes. Proc. natn. Acad. Sci. USA 84, 9228.
7. 7. Liu E., Hjelle B. & Bishop J. M. (1988) Transforming genes in chronic myelogenous leukemia. Proc. natn. Acad. Sci. USA 85, 1952.
8. 8. Inokuchi K., Amuro N., Futaki M., Dan K., Shinohara T., Kuriya S., Okazaki T. & Nomura T. (1991) Transforming gene and chromosome aberration in therapy-related leukemia and myelodysplastic syndrome. Ann. Hematol. 62, 211.
9. 9. Inokuchi K., Futaki M., Dan K. & Nomura T. (1994) Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia. Int. Med. 33, 189.